Literature DB >> 15786533

Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population.

Ping-An Zhang1, Jian-Min Wu, Yan Li, Xiang-Sheng Yang.   

Abstract

AIM: To investigate the polymorphisms of interleukin-18 (IL-18) gene promoters, and to disclose whether such polymorphisms are associated with susceptibility to chronic hepatitis B in Chinese Han population.
METHODS: Using polymerase chain reaction with sequence specific primers (PCR-SSP) method, the single nucleotide polymorphisms (SNPs) of the promoter region of IL-18 gene at position -607 and -137 were detected in 231 patients with chronic hepatitis B and 300 normal controls.
RESULTS: Allele C at position -607 in the promoter of IL-18 gene was detected in 48.7% of normal controls and 51.9% of patients, while allele A at position -607 was detected in 51.3% of normal controls and 48.1% of patients. The frequencies of -607CC, -607 CA and -607AA genotypes in normal controls were 22.0%, 53.3% and 24.7% respectively and in chronic hepatitis B patients were 26.8%, 50.2% and 23.0% respectively. Allele G at position -137 in the promoter of IL-18 gene was detected in 82.3% of normal controls and 88.5% of chronic hepatitis B patients, while allele C at position -137 was detected in 17.7% of normal controls and 11.5% of patients. The frequencies of -137GG, GC and CC genotype were 67.3%, 30.0% and 2.7% in normal controls respectively, while in chronic hepatitis B patients were 78.8%, 19.5% and 1.7% respectively. The frequency of -137GG genotype in chronic hepatitis B groups was significantly higher than that in normal controls (chi2 = 8.55, P = 0.003<0.05), whereas the frequencies of -607C/-137C and -607A/-137C haplotypes in chronic hepatitis B groups were significantly lower than that in normal controls. The association between genotypes of IL-18 promoter region polymorphisms and HBV copies showed that the frequency of -607AA genotype in high HBV-DNA copies groups was lower than that in low HBV-DNA copies groups (chi2 = 6.03, P = 0.014<0.05).
CONCLUSION: The polymorphisms of the promoter region of IL-18 gene at position -607 and -137 are closely associated with susceptibility to chronic hepatitis B. The people with allele C at position -137 in the promoter of IL-18 gene may be protected against HBV infection; moreover AA genotype at position -607 may be closely linked to inhibit HBV-DNA replication. These findings give some new clues to the study of pathogenesis of chronic hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786533      PMCID: PMC4305937          DOI: 10.3748/wjg.v11.i11.1594

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.

Authors:  T Hoshino; R H Wiltrout; H A Young
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Interleukin-18 promoter polymorphisms in type 1 diabetes.

Authors:  Adam Kretowski; Katarzyna Mironczuk; Anna Karpinska; Urszula Bojaryn; Maciej Kinalski; Zbigniew Puchalski; Ida Kinalska
Journal:  Diabetes       Date:  2002-11       Impact factor: 9.461

3.  Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation.

Authors:  V Giedraitis; B He; W X Huang; J Hillert
Journal:  J Neuroimmunol       Date:  2001-01-01       Impact factor: 3.478

4.  Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection.

Authors:  Irene Cacciola; Giovanni Cerenzia; Teresa Pollicino; Giovanni Squadrito; Stefania Castellaneta; Alessando R Zanetti; Giorgina Mieli-Vergani; Giovanni Raimondo
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

5.  Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis.

Authors:  R E El-Mezzein; T Matsumoto; H Nomiyama; T Miike
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

6.  [Effect of IL-18 on peripheral blood monocytes from chronic hepatitis B patients].

Authors:  Ying Sun; Huan-yong Chen; Fei Wang; Xin Zhang; Hong-qi Jiang; Feng-juan Shao; Si-he Zhu
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2003-08

7.  Association between interleukin-18 gene polymorphism 105A/C and asthma.

Authors:  S Higa; T Hirano; M Mayumi; M Hiraoka; Y Ohshima; M Nambu; E Yamaguchi; N Hizawa; N Kondo; E Matsui; Y Katada; A Miyatake; I Kawase; T Tanaka
Journal:  Clin Exp Allergy       Date:  2003-08       Impact factor: 5.018

8.  Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population.

Authors:  T Takada; E Suzuki; K Morohashi; F Gejyo
Journal:  Tissue Antigens       Date:  2002-07

9.  Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

Authors:  Kiminori Kimura; Kazuhiro Kakimi; Stefan Wieland; Luca G Guidotti; Francis V Chisari
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  [Polymorphism in codons 10 and 25 of the transforming growth factor-beta1 gene in Korean population and in patients with liver cirrhosis and hepatocellular carcinoma].

Authors:  Oh Sang Kwon; Suk Ho Song; Ki Tak Ju; Moon Gi Chung; Dong Kyun Park; Sun Suk Kim; Yeon Suk Kim; Yang Suh Koo; Yu Kyung Kim; Duck Joo Choi; Ju Hyun Kim; You Jin Hwang; Kwan Soo Byun; Chang Hong Lee
Journal:  Korean J Gastroenterol       Date:  2003-09
View more
  21 in total

1.  Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Authors:  Zhi-Tao Yang; Xin-Xin Zhang; Xiao-Fei Kong; Dong-Hua Zhang; Shen-Ying Zhang; Jie-Hong Jiang; Qi-Ming Gong; Gen-Di Jin; Zhi-Meng Lu
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection.

Authors:  Na Li; Yu-Feng Gao; Tian-Chen Zhang; Ping Chen; Xu Li; Fei Su
Journal:  World J Hepatol       Date:  2012-03-27

Review 3.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

4.  Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.

Authors:  Ping An; Chloe L Thio; Gregory D Kirk; Sharyne Donfield; James J Goedert; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

5.  IL-18 105 A>C polymorphism contributes to renal manifestations in patients with SLE.

Authors:  Teresa Warchoł; Margarita Lianeri; Mariusz Wudarski; Jan K Lacki; Paweł Piotr Jagodziński
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

6.  Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults.

Authors:  W Song; C M Wilson; S Allen; C Wang; Y Li; R A Kaslow; J Tang
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 7.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 8.  Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection.

Authors:  Semra Tunçbilek
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  Association of interleukin-18 gene variants with susceptibility to visceral leishmaniasis in Iranian population.

Authors:  Ali Moravej; Manoochehr Rasouli; Sadaf Asaei; Mehdi Kalani; Yaser Mansoori
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

10.  Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis.

Authors:  Arpita Sharma; Anuradha Chakraborti; Ashim Das; Radha Krishan Dhiman; Yogesh Chawla
Journal:  Immunology       Date:  2008-11-24       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.